Brca AND (genetic OR genomic) AND review - PubMed - NCBI

Brca AND (genetic OR genomic) AND review - PubMed - NCBI



From PubMed

PubMed comprises more than 27 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.

---

• PubMed links to genetics reviews articles for "Brca" 

Best matches for Brca AND (genetic OR genomic) AND review:

Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.Hoskins PJ et al. CA Cancer J Clin. (2017)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.Baretta Z et al. Medicine (Baltimore). (2016)

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Nelson HD et al. Ann Intern Med. (2014)

Search results

Items: 1 to 20 of 736

<< First< Prev

Page  of 37

Next >Last >>

Select item 306226571.

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans.

Kim H, Choi DH, Park W, Im YH, Ahn JS, Park YH, Nam SJ, Kim SW, Lee JE, Yu JH, Lee SK, Jung BY.

Hered Cancer Clin Pract. 2019 Jan 3;17:1. doi: 10.1186/s13053-018-0103-3. eCollection 2019.

PMID:

 

30622657

 

Free PMC Article

Similar articles

Select item 305526722.

Hereditary breast cancer; Genetic penetrance and current status with BRCA.

Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R, Pillai S, Lam AK, Gopalan V.

J Cell Physiol. 2018 Dec 14. doi: 10.1002/jcp.27464. [Epub ahead of print] Review.

PMID:

 

30552672

Similar articles

Select item 305449633.

Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

Nicolas E, Bertucci F, Sabatier R, Gonçalves A.

Cancers (Basel). 2018 Dec 11;10(12). pii: E506. doi: 10.3390/cancers10120506. Review.

PMID:

 

30544963

 

Free PMC Article

Similar articles

Select item 305396804.

Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma.

Zemanek T, Melichar B, Lovecek M, Soucek P, Mohelnikova-Duchonova B.

Pharmacogenomics. 2018 Dec 12. doi: 10.2217/pgs-2018-0073. [Epub ahead of print]

PMID:

 

30539680

Similar articles

Select item 304731255.

No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.

Jacobson M, Bernardini M, Sobel ML, Kim RH, McCuaig J, Allen L.

J Obstet Gynaecol Can. 2018 Nov;40(11):1497-1510. doi: 10.1016/j.jogc.2018.05.046.

PMID:

 

30473125

Similar articles

Select item 304546796.

Radiation-induced bystander and systemic effects serve as a unifying model system for genotoxic stress responses.

Burdak-Rothkamm S, Rothkamm K.

Mutat Res. 2018 Oct - Dec;778:13-22. doi: 10.1016/j.mrrev.2018.08.001. Epub 2018 Aug 17. Review.

PMID:

 

30454679

Similar articles

Select item 304479157.

Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis.

Marchetti C, De Felice F, Boccia S, Sassu C, Di Donato V, Perniola G, Palaia I, Monti M, Muzii L, Tombolini V, Benedetti Panici P.

Crit Rev Oncol Hematol. 2018 Dec;132:111-115. doi: 10.1016/j.critrevonc.2018.09.018. Epub 2018 Oct 3. Review.

PMID:

 

30447915

Similar articles

Select item 304285478.

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.

McCuaig JM, Armel SR, Care M, Volenik A, Kim RH, Metcalfe KA.

Cancers (Basel). 2018 Nov 13;10(11). pii: E435. doi: 10.3390/cancers10110435. Review.

PMID:

 

30428547

 

Free PMC Article

Similar articles

Select item 304006479.

Population Based Testing for Primary Prevention: A Systematic Review.

Manchanda R, Gaba F.

Cancers (Basel). 2018 Nov 5;10(11). pii: E424. doi: 10.3390/cancers10110424. Review.

PMID:

 

30400647

 

Free PMC Article

Similar articles

Select item 3035613810.

State-of-the-art strategies for targeting the DNA damage response in cancer.

Pilié PG, Tang C, Mills GB, Yap TA.

Nat Rev Clin Oncol. 2018 Oct 24. doi: 10.1038/s41571-018-0114-z. [Epub ahead of print] Review.

PMID:

 

30356138

Similar articles

Select item 3035224911.

Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.

Younes N, Zayed H.

Gene. 2019 Feb 5;684:154-164. doi: 10.1016/j.gene.2018.10.044. Epub 2018 Oct 22. Review.

PMID:

 

30352249

Similar articles

Select item 3035198112.

Targeted and immuno-biology driven treatment strategies for triple-negative breast cancer: current knowledge and future perspectives.

Fremd C, Jaeger D, Schneeweiss A.

Expert Rev Anticancer Ther. 2018 Oct 23:1-14. doi: 10.1080/14737140.2019.1537785. [Epub ahead of print]

PMID:

 

30351981

Similar articles

Select item 3034541213.

Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in GenomeIntegrity and Cancer.

Chen CC, Feng W, Lim PX, Kass EM, Jasin M.

Annu Rev Cancer Biol. 2018 Mar;2:313-336. doi: 10.1146/annurev-cancerbio-030617-050502. Epub 2017 Dec 1.

PMID:

 

30345412

 

Free PMC Article

Similar articles

Select item 3030572314.

Family-based germline sequencing in children with cancer.

Kuhlen M, Taeubner J, Brozou T, Wieczorek D, Siebert R, Borkhardt A.

Oncogene. 2018 Oct 10. doi: 10.1038/s41388-018-0520-9. [Epub ahead of print] Review.

PMID:

 

30305723

Similar articles

Select item 3029509115.

Gynecological-endocrinological aspects in women carriers of BRCA1/2 gene mutations.

Doren A, Vecchiola A, Aguirre B, Villaseca P.

Climacteric. 2018 Oct 8:1-7. doi: 10.1080/13697137.2018.1514006. [Epub ahead of print]

PMID:

 

30295091

Similar articles

Select item 3029371016.

The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis.

Staropoli N, Ciliberto D, Del Giudice T, Iuliano E, Cucè M, Grillone F, Salvino A, Barbieri V, Russo A, Tassone P, Tagliaferri P.

Crit Rev Oncol Hematol. 2018 Nov;131:83-89. doi: 10.1016/j.critrevonc.2018.08.011. Epub 2018 Sep 3. Review.

PMID:

 

30293710

Similar articles

Select item 3027888317.

[DNA damage repair: An emerging strategy in metastatic prostate cancer].

Loriot Y, Meynard G, Klajer E, Bolognini C, Gassian N, Thiery-Vuillemin A.

Bull Cancer. 2018 Oct;105(10):944-954. doi: 10.1016/j.bulcan.2018.05.017. Epub 2018 Sep 29. Review. French.

PMID:

 

30278883

Similar articles

Select item 3024089818.

Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer.

AlHilli MM, Al-Hilli Z.

J Minim Invasive Gynecol. 2018 Sep 19. pii: S1553-4650(18)31215-9. doi: 10.1016/j.jmig.2018.09.767. [Epub ahead of print] Review.

PMID:

 

30240898

Similar articles

Select item 3023132819.

Innovative Strategies: Targeting Subtypes in Metastatic Breast Cancer.

Pegram MD, Zong Y, Yam C, Goetz MP, Moulder SL.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):65-77. doi: 10.1200/EDBK_200715. Review.

PMID:

 

30231328

 

Free Article

Similar articles

Select item 3017824220.

Genomic Profiling and Potentially Targetable Alterations in Pancreatic Ductal Adenocarcinoma.

Gleeson FC, Levy MJ.

Curr Treat Options Gastroenterol. 2018 Dec;16(4):441-448. doi: 10.1007/s11938-018-0195-x. Review.

PMID:

 

30178242

Similar articles